1
|
Zhao J, Adiele N, Gomes D, Malovichko M, Conklin DJ, Ekuban A, Luo J, Gripshover T, Watson WH, Banerjee M, Smith ML, Rouchka EC, Xu R, Zhang X, Gondim DD, Cave MC, O’Toole TE. Obesogenic polystyrene microplastic exposures disrupt the gut-liver-adipose axis. Toxicol Sci 2024; 198:210-220. [PMID: 38291899 PMCID: PMC10964747 DOI: 10.1093/toxsci/kfae013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2024] Open
Abstract
Microplastics (MP) derived from the weathering of polymers, or synthesized in this size range, have become widespread environmental contaminants and have found their way into water supplies and the food chain. Despite this awareness, little is known about the health consequences of MP ingestion. We have previously shown that the consumption of polystyrene (PS) beads was associated with intestinal dysbiosis and diabetes and obesity in mice. To further evaluate the systemic metabolic effects of PS on the gut-liver-adipose tissue axis, we supplied C57BL/6J mice with normal water or that containing 2 sizes of PS beads (0.5 and 5 µm) at a concentration of 1 µg/ml. After 13 weeks, we evaluated indices of metabolism and liver function. As observed previously, mice drinking the PS-containing water had a potentiated weight gain and adipose expansion. Here we found that this was associated with an increased abundance of adipose F4/80+ macrophages. These exposures did not cause nonalcoholic fatty liver disease but were associated with decreased liver:body weight ratios and an enrichment in hepatic farnesoid X receptor and liver X receptor signaling. PS also increased hepatic cholesterol and altered both hepatic and cecal bile acids. Mice consuming PS beads and treated with the berry anthocyanin, delphinidin, demonstrated an attenuated weight gain compared with those mice receiving a control intervention and also exhibited a downregulation of cyclic adenosine monophosphate (cAMP) and peroxisome proliferator-activated receptor (PPAR) signaling pathways. This study highlights the obesogenic role of PS in perturbing the gut-liver-adipose axis and altering nuclear receptor signaling and intermediary metabolism. Dietary interventions may limit the adverse metabolic effects of PS consumption.
Collapse
Affiliation(s)
- Jingjing Zhao
- Division of Environmental Medicine, Department of Medicine, School of Medicine, Christina Lee Brown Envirome Institute, University of Louisville, Louisville, Kentucky 40202, USA
- The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky 40202, USA
| | - Ngozi Adiele
- Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
| | - Daniel Gomes
- Division of Environmental Medicine, Department of Medicine, School of Medicine, Christina Lee Brown Envirome Institute, University of Louisville, Louisville, Kentucky 40202, USA
- Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
| | - Marina Malovichko
- Division of Environmental Medicine, Department of Medicine, School of Medicine, Christina Lee Brown Envirome Institute, University of Louisville, Louisville, Kentucky 40202, USA
- The Superfund Research Center, University of Louisville, Louisville, Kentucky 40202, USA
| | - Daniel J Conklin
- Division of Environmental Medicine, Department of Medicine, School of Medicine, Christina Lee Brown Envirome Institute, University of Louisville, Louisville, Kentucky 40202, USA
- The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky 40202, USA
- The Superfund Research Center, University of Louisville, Louisville, Kentucky 40202, USA
| | - Abigail Ekuban
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
- The Hepatobiology and Toxicology Center, University of Louisville, Louisville, Kentucky 40202, USA
| | - Jianzhu Luo
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
| | - Tyler Gripshover
- Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
- The Superfund Research Center, University of Louisville, Louisville, Kentucky 40202, USA
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
| | - Walter H Watson
- The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky 40202, USA
- Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
- The Hepatobiology and Toxicology Center, University of Louisville, Louisville, Kentucky 40202, USA
| | - Mayukh Banerjee
- The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky 40202, USA
- Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
| | - Melissa L Smith
- The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky 40202, USA
- Department of Biochemistry & Molecular Genetics, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
| | - Eric C Rouchka
- Department of Biochemistry & Molecular Genetics, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
- KY INBRE Bioinformatics Core, University of Louisville, Louisville, Kentucky 40202, USA
| | - Raobo Xu
- Department of Chemistry, School of Arts and Sciences, University of Louisville, Louisville, Kentucky 40292, USA
- Center for Regulatory and Environmental Analytical Metabolomics, University of Louisville, Louisville, Kentucky 40292, USA
| | - Xiang Zhang
- The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky 40202, USA
- The Hepatobiology and Toxicology Center, University of Louisville, Louisville, Kentucky 40202, USA
- Center for Regulatory and Environmental Analytical Metabolomics, University of Louisville, Louisville, Kentucky 40292, USA
- Division of Analytic Chemistry, Department of Chemistry, School of Arts and Sciences, University of Louisville, Louisville, Kentucky 40292, USA
- The Alcohol Research Center, University of Louisville, Louisville, Kentucky 40202, USA
| | - Dibson D Gondim
- Department of Pathology and Laboratory, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
| | - Matthew C Cave
- The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky 40202, USA
- Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
- The Superfund Research Center, University of Louisville, Louisville, Kentucky 40202, USA
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
- The Hepatobiology and Toxicology Center, University of Louisville, Louisville, Kentucky 40202, USA
- Department of Biochemistry & Molecular Genetics, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
- The Robley Rex Veterans Affairs Medical Center, Louisville, KY 40206, USA
| | - Timothy E O’Toole
- Division of Environmental Medicine, Department of Medicine, School of Medicine, Christina Lee Brown Envirome Institute, University of Louisville, Louisville, Kentucky 40202, USA
- The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky 40202, USA
- The Superfund Research Center, University of Louisville, Louisville, Kentucky 40202, USA
| |
Collapse
|
2
|
Gondim DD, Al-Obaidy KI, Idrees MT, Eble JN, Cheng L. Artificial intelligence-based multi-class histopathologic classification of kidney neoplasms. J Pathol Inform 2023; 14:100299. [PMID: 36915914 PMCID: PMC10006494 DOI: 10.1016/j.jpi.2023.100299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Revised: 02/03/2023] [Accepted: 02/11/2023] [Indexed: 02/17/2023] Open
Abstract
Artificial intelligence (AI)-based techniques are increasingly being explored as an emerging ancillary technique for improving accuracy and reproducibility of histopathological diagnosis. Renal cell carcinoma (RCC) is a malignancy responsible for 2% of cancer deaths worldwide. Given that RCC is a heterogenous disease, accurate histopathological classification is essential to separate aggressive subtypes from indolent ones and benign mimickers. There are early promising results using AI for RCC classification to distinguish between 2 and 3 subtypes of RCC. However, it is not clear how an AI-based model designed for multiple subtypes of RCCs, and benign mimickers would perform which is a scenario closer to the real practice of pathology. A computational model was created using 252 whole slide images (WSI) (clear cell RCC: 56, papillary RCC: 81, chromophobe RCC: 51, clear cell papillary RCC: 39, and, metanephric adenoma: 6). 298,071 patches were used to develop the AI-based image classifier. 298,071 patches (350 × 350-pixel) were used to develop the AI-based image classifier. The model was applied to a secondary dataset and demonstrated that 47/55 (85%) WSIs were correctly classified. This computational model showed excellent results except to distinguish clear cell RCC from clear cell papillary RCC. Further validation using multi-institutional large datasets and prospective studies are needed to determine the potential to translation to clinical practice.
Collapse
Affiliation(s)
- Dibson D Gondim
- Department of Pathology, University of Louisville School of Medicine, Louisville, KY 40202, USA
| | - Khaleel I Al-Obaidy
- Department of Pathology and Laboratory Medicine, Henry Ford Health, 2799 West Grand Blvd, Detroit, MI 48202, USA
| | - Muhammad T Idrees
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | - John N Eble
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | - Liang Cheng
- Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Lifespan Academic Medical Center, and the Legorreta Cancer Center at Brown University, Providence, RI, USA
| |
Collapse
|
3
|
Abdeltawab HA, Khalifa FA, Ghazal MA, Cheng L, El-Baz AS, Gondim DD. A deep learning framework for automated classification of histopathological kidney whole-slide images. J Pathol Inform 2022; 13:100093. [PMID: 36268061 PMCID: PMC9576982 DOI: 10.1016/j.jpi.2022.100093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
Abstract
Background Methods Results Conclusions
Collapse
|
4
|
Eiswerth MJ, Heckroth MA, Ismail A, Gondim DD, Kaufman R. Infliximab-Induced Vanishing Bile Duct Syndrome. Cureus 2022; 14:e21940. [PMID: 35273881 PMCID: PMC8901196 DOI: 10.7759/cureus.21940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/05/2022] [Indexed: 12/02/2022] Open
Abstract
Drug-induced liver injury (DILI) is a spectrum of pathology that can be classified by mechanism of injury or by type of observed hepatotoxicity. Vanishing bile duct syndrome (VBDS) is a group of acquired and genetic disorders that cause the destruction and disappearance of intrahepatic bile ducts, and cholestasis. VBDS typically presents with severe cholestatic hepatitis and can have immunoallergic features. Infliximab has been reported to rarely cause a cholestatic pattern of liver injury due to ductopenia characteristic of VBDS. Herein we present a clinical case of infliximab-induced DILI resulting in VBDS.
Collapse
|
5
|
Gondim DD, Oblak A, Murrell JR, Richardson R, Epperson F, Ross OA, Ghetti B. Diffuse Lewy Body Disease and Alzheimer Disease: Neuropathologic Phenotype Associated With the PSEN1 p.A396T Mutation. J Neuropathol Exp Neurol 2020; 78:585-594. [PMID: 31165862 DOI: 10.1093/jnen/nlz039] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
In sporadic and dominantly inherited Alzheimer disease (AD), aggregation of both tau and α-synuclein may occur in neurons. Aggregates of either protein occur separately or coexist in the same neuron. It is not known whether the coaggregation of tau and α-synuclein in dominantly inherited AD occurs in association with specific mutations of the APP, PSEN1, or PSEN2 genes. The aim of this study was to provide the first characterization of the neuropathologic phenotype associated with the PSEN1 p.A396T mutation in a man who was clinically diagnosed as having AD, but for whom the PSEN1 mutation was found postmortem. The proband, who was 56 years old when cognitive impairment first manifested, died at 67 years of age. Neuropathologically, 3 proteinopathies were present in the brain. Widespread α-synuclein-immunopositive neuronal inclusions suggested a diagnosis of diffuse Lewy body disease (DLBD), while severe and widespread tau and amyloid-β pathologies confirmed the clinical diagnosis of AD. Immunohistochemistry revealed the coexistence of tau and α-synuclein aggregates in the same neuron. Neuropathologic and molecular studies in brains of carriers of the PSEN1 p.A396T mutation or other PSEN1 or PSEN2 mutations associated with the coexistence of DLBD and AD are needed to clarify whether tau and α-synuclein proteinopathies occur independently or whether a relationship exists between α-synuclein and tau that might explain the mechanisms of coaggregation.
Collapse
Affiliation(s)
- Dibson D Gondim
- Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
| | - Adrian Oblak
- Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
| | - Jill R Murrell
- The Children's Hospital of Philadelphia, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia
| | - Rose Richardson
- Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
| | - Francine Epperson
- Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
| | - Owen A Ross
- Department of Neuroscience, Mayo Clinic, Jacksonville, Florida
| | - Bernardino Ghetti
- Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
| |
Collapse
|
6
|
Flack CK, Calaway AC, Miller BL, Picken MM, Gondim DD, Idrees MT, Abel EJ, Gupta GN, Boris RS. Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma. Urol Oncol 2019; 37:811.e17-811.e21. [PMID: 31451335 DOI: 10.1016/j.urolonc.2019.06.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2018] [Revised: 04/06/2019] [Accepted: 06/05/2019] [Indexed: 01/20/2023]
Abstract
INTRODUCTION Oncocytic neoplasms are renal tumors similar to oncocytoma, but their morphologic variations preclude definitive diagnosis. This somewhat confusing diagnosis can create treatment and surveillance challenges for the treating urologist. We hypothesize that these subtle morphologic variations do not drastically affect the malignant potential of these tumors, and we sought to demonstrate this by comparing clinical outcomes of oncocytic neoplasms to those of classic oncocytoma and chromophobe. METHODS We gathered demographic and outcomes data for patients with variant oncocytic tumors. Oncologic surveillance was conducted per institutional protocol in accordance with NCCN guidelines. Descriptive statistics were used to compare incidence of metastasis and death against those for patients with oncocytoma and chromophobe. Three hundred and fifty-one patients were analyzed: 164 patients with oncocytoma, 28 with oncocytic neoplasms, and 159 with chromophobe tumors. RESULTS Median follow-up time for the entire cohort was 32.4 months, (interquartile range 9.2-70.0). Seventeen total patients (17/351, 4.9%) died during the course of the study. In patients with oncocytoma or oncocytic neoplasm, none were known to metastasize or die of their disease. Only chromophobe tumors >6 cm in size in our series demonstrated metastatic progression and approximately half of these metastasized tumors demonstrated sarcomatoid changes. CONCLUSION Variant oncocytic neoplasms appear to have a natural course similar to classic oncocytoma. These tumors appear to have no metastatic potential, and oncologic surveillance may not be indicated after surgery.
Collapse
Affiliation(s)
- Chandra K Flack
- Departments of Urology, Indiana University School of Medicine, Indianapolis, IN
| | - Adam C Calaway
- Departments of Urology, Indiana University School of Medicine, Indianapolis, IN
| | - Brady L Miller
- Department of Urology, University of Wisconsin School of Medicine, Madison, WI
| | - Maria M Picken
- Departments of Pathology, Loyola University School of Medicine, Maywood, IL
| | - Dibson D Gondim
- Departments of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
| | - Muhammad T Idrees
- Departments of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
| | - E Jason Abel
- Department of Urology, University of Wisconsin School of Medicine, Madison, WI
| | - Gopal N Gupta
- Departments of Urology, Loyola University School of Medicine, Maywood, IL
| | - Ronald S Boris
- Departments of Urology, Indiana University School of Medicine, Indianapolis, IN.
| |
Collapse
|
7
|
Fetcko K, Gondim DD, Bonnin JM, Dey M. Cervical cancer metastasis to the brain: A case report and review of literature. Surg Neurol Int 2017; 8:181. [PMID: 28868193 PMCID: PMC5569407 DOI: 10.4103/sni.sni_111_17] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2017] [Accepted: 05/30/2017] [Indexed: 01/08/2023] Open
Abstract
Background: Intracranial metastasis from cervical cancer is a rare occurrence. Methods: In this study we describe a case of cervical cancer metastasis to the brain and perform an extensive review of literature from 1956 to 2016, to characterize clearly the clinical presentation, treatment options, molecular markers, targeted therapies, and survival of patients with this condition. Results: An elderly woman with history of cervical cancer in remission, presented 2 years later with a right temporo-parietal tumor, which was treated with surgery and subsequent stereotactic radiosurgery (SRS) to the resection cavity. She then returned 5 months later with a second solitary right lesion; she again underwent surgery and SRS to the resection cavity with no signs of recurrence 6 months later. According to the reviewed literature, the most common clinical presentation included females with median age of 48 years; presenting symptoms such as headache, weakness/hemiplegia/hemiparesis, seizure, and altered mental status (AMS)/confusion; multiple lesions mostly supratentorially located; poorly differentiated squamous cell carcinoma; and additional recurrences at other sites. The best approach to treatment is a multimodal plan, consisting of SRS or whole brain radiation therapy (WBRT) for solitary brain metastases followed by chemotherapy for systemic disease, surgery and WBRT for solitary brain lesions without systemic disease, and SRS or WBRT followed by chemotherapy for palliative care. The overall prognosis is poor with a mean and median survival time from diagnosis of brain metastasis of 7 and 4.6 months, respectively. Conclusion: Future efforts through large prospective randomized trials are warranted to better describe the clinical presentation and identify more effective treatment plans.
Collapse
Affiliation(s)
- Kaleigh Fetcko
- Department of Neurosurgery, Indiana University, Indianapolis, Indiana, USA
| | - Dibson D Gondim
- Division of Neuropathology, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Jose M Bonnin
- Division of Neuropathology, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Mahua Dey
- Department of Neurosurgery, Indiana University, Indianapolis, Indiana, USA
| |
Collapse
|
8
|
Jacob JM, Williamson SR, Gondim DD, Leese JA, Terry C, Grignon DJ, Boris RS. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms. Urology 2015; 86:956-61. [DOI: 10.1016/j.urology.2015.06.015] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2015] [Revised: 06/02/2015] [Accepted: 06/16/2015] [Indexed: 01/30/2023]
|
9
|
Diehl DL, Johal AS, Khara HS, Stavropoulos SN, Al-Haddad M, Ramesh J, Varadarajulu S, Aslanian H, Gordon SR, Shieh FK, Pineda-Bonilla JJ, Dunkelberger T, Gondim DD, Chen EZ. Endoscopic ultrasound-guided liver biopsy: a multicenter experience. Endosc Int Open 2015; 3:E210-5. [PMID: 26171433 PMCID: PMC4486032 DOI: 10.1055/s-0034-1391412] [Citation(s) in RCA: 72] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/05/2014] [Accepted: 12/24/2014] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND AND AIMS Endoscopic ultrasound-guided (EUS) liver biopsy (LB) is proposed as a newer method that offers several advantages over existing techniques for sampling liver tissue. This study evaluated the diagnostic yield of EUS-LB as the primary outcome measure. In addition, the safety of the technique in a large patient cohort was assessed. PATIENTS AND METHODS Patients undergoing EUS for evaluation of elevated liver enzymes or hepatic disease were included in this prospective, non-randomized, multicenter study. EUS-LB was performed with EUS-fine needle aspiration (FNA; 19-gauge needle). Tissue was formalin-fixed and stained with hematoxylin and eosin, and trichrome. Using a microscope micrometer, specimen length was measured and the number of complete portal triads (CPTs) were counted. The main outcome measure was to assess the diagnostic yield of EUS-LB, and to monitor for any procedure-related complications. RESULTS Patients (110; median age, 53 years; 62 women) underwent EUS-LB at eight centers. The indication was abnormal liver enzymes in 96 patients. LB specimens sufficient for pathological diagnosis were obtained in 108 of 110 patients (98 %). The overall tissue yield from 110 patients was a median aggregate length of 38 mm (range, 0 - 203), with median of 14 CPTs (range, 0 - 68). There was no statistical difference in the yield between bilobar, left lobe only, or right lobe only biopsies. There was one complication (0.9 %) where self-limited bleeding occurred in a coagulopathic and thrombocytopenic patient. This complication was managed conservatively. CONCLUSIONS EUS-guided LB was a safe technique that yields tissue adequate for diagnosis among 98 % of patients evaluated.
Collapse
Affiliation(s)
- David L. Diehl
- Geisinger Medical Center, Department of Gastroenterology and Nutrition, Danville, Pennsylvania, United States
| | - Amitpal S. Johal
- Geisinger Medical Center, Department of Gastroenterology and Nutrition, Danville, Pennsylvania, United States
| | - Harshit S. Khara
- Geisinger Medical Center, Department of Gastroenterology and Nutrition, Danville, Pennsylvania, United States
| | - Stavros N. Stavropoulos
- Winthrop University Hospital, Departments of Gastroenterology, Hepatology and Nutrition, Mineola, New York, United States
| | - Mohammed Al-Haddad
- Indiana University, Department of Gastroenterology and Hepatology, Indianapolis, Indiana, United States
| | - Jayapal Ramesh
- University of Alabama at Birmingham, Division of Gastroenterology and Hepatology, Birmingham, Alabama, United States
| | - Shyam Varadarajulu
- Florida Hospital, Center for Interventional Endoscopy, Orlando, Florida, United States
| | - Harry Aslanian
- Yale University School of Medicine, Department of Medicine, Section of Digestive Diseases, New Haven, Connecticut, United States
| | - Stuart R. Gordon
- Dartmouth-Hitchcock Medical Center, Department of Gastroenterology, Lebanon, New Hampshire, United States
| | - Frederick K. Shieh
- Geisinger Medical Center, Department of Gastroenterology and Nutrition, Danville, Pennsylvania, United States
| | - Jonh J. Pineda-Bonilla
- Geisinger Medical Center, Department of Gastroenterology and Nutrition, Danville, Pennsylvania, United States
| | - Theresa Dunkelberger
- Geisinger Medical Center, Department of Gastroenterology and Nutrition, Danville, Pennsylvania, United States
| | - Dibson D. Gondim
- Indiana University, Department of Pathology and Laboratory Medicine, Indianapolis, Indiana, United States
| | - Eric Z. Chen
- Geisinger Medical Center, Department of Gastroenterology and Nutrition, Danville, Pennsylvania, United States
| |
Collapse
|
10
|
Jacob JM, Gondim DD, Pedrosa JA, Idrees MT, Boris RS. MP30-21 PATHOLOGIC VARIANCES IN TUMOR CAPSULE PROPERTIES OF CLEAR CELL RENAL CELL CARCINOMA ACROSS VARIOUS CLINICAL STAGES. J Urol 2014. [DOI: 10.1016/j.juro.2014.02.2580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
11
|
Costa CM, Gondim DD, Gondim DD, Soares HB, Ribeiro AGCD, Silva I, Winkler E, Celi L, Guerreiro AMG, Leite CRM. S2DIA: a diagnostic system for Diabetes mellitus using SANA platform. Annu Int Conf IEEE Eng Med Biol Soc 2012; 2012:6078-6081. [PMID: 23367315 PMCID: PMC5679197 DOI: 10.1109/embc.2012.6347380] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Currently, Diabetes is a very common disease around the world, and with an increase in sedentary lifestyles, obesity and an aging population the number of people with Diabetes worldwide will increase by more than 50%. In this context, the MIT (Massachusetts Institute of Technology) developed the SANA platform, which brings the benefits of information technology to the field of healthcare. It offers healthcare delivery in remote areas, improves patient access to medical specialists for faster, higher quality, and more cost effective diagnosis and intervention. For these reasons, we developed a system for diagnosis of Diabetes using the SANA platform, called S2DIA. It is the first step towards knowing the risks for type 2 Diabetes, and it will be evaluated, especially, in remote/poor areas of Brazil.
Collapse
Affiliation(s)
- Clayton M Costa
- Laboratory of software engineering of the Universidade do Estado do Rio Grande do Norte (UERN) Mossoro, RN, Brazil.
| | | | | | | | | | | | | | | | | | | |
Collapse
|